About this trial
Obstructive sleep apnea syndrome (OSA) is marked by repeated upper airway obstructions during sleep, affecting approximately 14% of men and 5% of women aged 30-70 years.
However, precise clinical prediction tools for selecting optimal treatment strategies are lacking. This study aims to develop an automated treatment clustering system using artificial intelligence to classify patients based on etiology into (i) anatomical factors, (ii) reduced muscle responsiveness, and (iii) other non-anatomical factors. This system will analyze physiological sleep assessments, such as electromyography (EMG) and pneumotachographs, from a retrospective polysomnography (PSG) database. Cross-validation will be conducted on new OSA patients undergoing various management strategies, including surgical intervention, CPAP therapy, and oropharyngeal training (delivered face-to-face or via telerehabilitation). This system aims to enhance clinicians' ability to predict treatment success rates and improve patient outcomes.
Eligibility criteria
Qualifiers
OSA patients
Aged over 20 years
Disqualifiers
BMI≧ 32
Central or mixed types of sleep apnea
A history of malignancy or infection of the head and neck region and laryngeal trauma
Craniofacial malformation
Trial design
Treatments tested in this trial
- Control Group
- Surgical Intervention
- Oropharyngeal Training (face-to-face)
- Oropharyngeal Training (telerehabilitation)
- Continuous Positive Airway Pressure